John Glencross is CEO of Calculus Capital, which he co-created, launching the UK’s 1st approved EIS fund in 1999. He is an EISA board member, a member of the EISA Tax and Technical Committee and a member of the EU state aid committee. As a respected industry leader, John liaises frequently with HMT and HMRC, most recently as part of the Patient Capital Review.
